Of 195 breast cancer samples with TOP1 and CDH3 available, 57 samples were positive for TOP1 and CDH3 and 138 samples were TOP1 and/or CDH3 negative (79 positive for either of the two markers and 59 samples negative for both markers). This evidence concerns the gene TOP1 and breast cancer.